Commercial Physical & Biological Research
Stocks Ranked by
Market Capitalization

Filters
IQV stock icon
IQVIA
IQV
1
$42.6B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
7%
upside
19 forecasts
Learn more
CRL stock icon
Charles River Laboratories
CRL
2
$12.4B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
4%
upside
11 forecasts
Learn more
MEDP stock icon
Medpace
MEDP
3
$12.2B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
1%
downside
6 forecasts
Learn more
INCY stock icon
Incyte
INCY
4
$12.1B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
37%
upside
19 forecasts
Learn more
NRC stock icon
National Research Corporation Common Stock (Delaware)
NRC
5
$813M
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
ABSI stock icon
Absci Corporation Common Stock
ABSI
6
$658M
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
24%
upside
9 forecasts
Learn more
OABI stock icon
OmniAb, Inc. Common Stock
OABI
7
$591M
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
74%
upside
5 forecasts
Learn more
MXCT stock icon
MaxCyte, Inc. Common Stock
MXCT
8
$417M
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
117%
upside
3 forecasts
Learn more
NOTV stock icon
Inotiv, Inc. Common Stock
NOTV
9
$154M
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
LUNA stock icon
Luna Innovations Incorporated
LUNA
10
$90.2M
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
11
$34.7M
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
BIAF stock icon
bioAffinity Technologies, Inc. Common Stock
BIAF
12
$26.5M
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
ONMD
OneMedNet Corp Class A Common Stock
ONMD
13
$15.3M
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
FOXO
FOXO Technologies Inc.
FOXO
14
$2.8M
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
ISPC stock icon
iSpecimen Inc. Common Stock
ISPC
15
$2.06M
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more